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Abstract  
 
Collectin-11 is a recently described soluble C-type lectin, a pattern recognition molecule of the innate 
immune system that has distinct roles in host defense, embryonic development as well as acute 
inflammation. However, little is known to date regarding its role in tissue fibrosis. Here, we report a 
pathogenic role for collectin-11 in renal tubulointerstitial fibrosis. Compared to wild-type littermate 
controls we found that collectin-11-/- mice had significantly reduced renal chronic inflammation and 
tubulointerstitial fibrosis, as evidenced by reduced renal functional impairment, tubular injury, renal 
leukocyte infiltration, renal tissue inflammation/fibrogenesis and collagen deposition in the kidneys 
following native renal ischemia/reperfusion (IR) injury. Similarly, collectin-11-/- kidney grafts displayed 
significantly reduced tubular injury and collagen deposition compared with collectin-11+/+ kidney grafts 
following syngeneic kidney transplantation. Mechanistic analyses revealed that collectin-11has potent 
effects in promoting leukocyte migration and stimulating renal fibroblast proliferation in vitro in a 
carbohydrate-dependent manner. Our findings demonstrate a previously unknown pathogenic role for 
collectin-11 in the development of tubulointerstitial fibrosis and suggest that local presence of collectin-
11promotes the fibrosis through its effects on leukocyte chemotaxis and renal fibroblast proliferation, 
in addition to triggering complement activation and acute inflammation. It provides a novel insight into 
pathogenesis of tubulointerstitial fibrosis and will have implications for chronic kidney disease 
mediated by other causes.  
 
Introduction   
 
Chronic kidney disease (CKD) is a progressive loss of kidney function over a period of time. CKD was 
ranked 19th in the list of causes for global deaths in 2013. Prevalence of CKD is estimated to be 8-
16% worldwide and expected to rise substantially in the coming decades.1 Acute kidney injury (AKI) is 
one of the main causes of CKD, among other causes (e.g. diabetes and hypertension, infectious 
glomerulonephritis, renal vasculitis).2 Renal fibrosis is the principal process underlying of the 
progression of CKD to end-stage renal disease (ESRD). Progressive tubulointerstitial fibrosis is the 
final common pathway for all kidney diseases leading to ESRD. As there are currently no specific 
treatments for tubulointerstitial fibrosis, a deeper understanding of molecular and cellular basis of 
tubulointerstitial fibrosis will be beneficial to the development of effective strategies that diminish or 
even reverse tubulointerstitial fibrosis in CKD. 
 
Renal tubulointerstitial fibrosis is characterized by progressive loss of renal function and renal 
histological lesions mainly including inflammatory cell infiltration, tubule damage (e.g. tubular atrophy, 
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tubule loss) and accumulation of extracellular matrix (collagen deposition).3 The pathogenesis of 
tubulointerstitial fibrosis is complex, involving multiple cell types and molecular pathways.4, 5 The major 
cell type involved in production of extracellular matrix (ECM) is the myofibroblast which produces a 
large amount of collagen I (Col I) and fibronectin (FN).6, 7 Myofibroblasts mainly differentiate from renal 
interstitial fibroblasts. Other types of cells in the kidney such as bone marrow-derived fibrocystic, 
stromal mesenchymal cells, and renal tubular epithelial cells have been reported to be able to 
transform into myofibroblasts.8 The inflammatory microenvironment of the kidney following renal injury 
is thought to play a key role in determining the dynamic balance between tissue destruction and 
repair, and ongoing inflammation including inflammatory cell infiltration and local production/release of 
pro-inflammatory and pro-fibrogenic molecules drives the fibrotic process.9 
 
Collectins (soluble collagen us C-type lectins) are a part of the innate immune system.10, 11 Well 
described collectins include mannose-binding lectin (MBL) and lung surfactant proteins (e.g. SP-A). 
They function as pattern recognition receptors that bind to carbohydrates or carbohydrate moieties on 
the surface of pathogens and host cells, and accordingly have important roles both in host defence 
and the regulation of cellular responses.12-14 Collectin-11 (CL-11; also known as CL-K1 and encoded 
by COLEC11) is a recently described memb r of the collectin family and displays structural similarities 
with MBL, SP-A and SP-D. CL-11 consists of a carbohydrate recognition domain (CRD), followed by a 
neck region and a collagen-like region and is known to bind to various molecules/molecular patterns 
(e.g. monosaccharides, mannose-containing glycans, LPS, DNA, microorganisms), via interaction with 
the  CRD.15-18 CL-11 has a wide tissue distribution; high-level expression was found in the kidney, liver 
and adrenal gland.17 CL-11 is known to play important roles in embryonic development and host 
defense,19, 20 while relatively little is currently known about the pathogenic roles of CL-11.  
 
Our recent work in a murine model of renal ischemia/reperfusion (IR) injury demonstrated that CL-11 
has a pathogenic role in AKI.21 However, the impact of CL-11 on chronic renal inflammation and tissue 
fibrosis is presently unknown. Such information will improve our understanding of diverse functions of 
CL-11 in the pathogenesis of renal injury. Previous studies have shown that many factors (e.g. Wnt 
pathway, Hedgehog pathway, Gremlin1, TGF-β) responsible for the control of embryonic devolvement 
are also key players in tissue repair and fibrosis.22-25 Given the role of CL-11 in embryonic 
devolvement and its potential for regulation of diverse cellular processes, we hypothesized that CL-11 
also plays important roles in renal fibrosis. In the present study, we employed two models (i.e. bilateral 
renal IR injury and syngeneic kidney transplantation) in CL-11-/- mice to interrogate the role of CL-11 in 
the development of renal tubulointerstitial fibrosis. We also performed a series of ex vivo analyses and 
in vitro experiments (using primarily cultured murine renal fibroblasts and peritoneal 
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exudate leukocytes) to explore the mechanisms by which CL-11 promotes renal fibrosis. Our data 
demonstrate a pathogenic role for CL-11 in promoting chronic renal inflammation and tubulointerstitial 
fibrosis. The mechanism by which CL-11 mediates pro-fibrotic effects involves both the promotion of 
leukocyte migration and stimulation of renal fibroblast proliferation. 
 
Results 
 
CL-11 mediates tubule damage and renal function impairment in the late phase of renal IR 
injury  
 
To assess the impact of CL-11 on renal function and histological injury during the late phase of renal 
IR injury, we induced bilateral renal ischemia (30 min) in CL-11+/+ and CL-11-/- mice, followed by 
reperfusion up to 7 days. Renal function was evaluated at 2 and 7 days post-reperfusion by measuring 
blood urea nitrogen (BUN), and significantly lower BUN levels were observed in CL-11-/- mice at both 
time points, compared with CL-11+/+ mice (Fig. 1a), indicating there was less impairment of renal 
function in CL-11-/- mice. CL-11-/- mice also displayed less severe renal histological lesions (i.e. 
proximal tubule brush border loss, tubule n crosis, tubule atrophy, protein casting, cellular infiltration 
in the cortical medullary junction) at 7 days post-reperfusion when compared to CL-11+/+ controls (Fig. 
1b). Histopathological scores also confirmed the attenuation of renal lesions in the CL-11-/- mice (Fig. 
1c). Collectively, these results demonstrate that CL-11 deficiency not only protects mice from AKI, but 
also reduces tubular damage and renal function impairment in the late phase of IR injury. 
   
CL-11 is required for accumulation of ECM in the kidney following renal IR  
 
Accumulation of ECM (collagen deposition) in the kidney following renal IR injury (7 days post-
reperfusion) was initially assessed by Sirius red staining. Compared to CL-11+/+ mice, CL-11-/- mice 
displayed a significant reduction of Sirius red staining in the tubular interstitium (Fig. 2a, 2b). 
Accumulation of ECM was further analyzed by immunohistochemistry for detection of ECM proteins 
(COL I, FN) and cytoskeletal protein (vimentin). Compared to CL-11+/+ mice, CL-11-/- mice exhibited 
markedly reduced COL I and FN deposition and vimentin expression in the tubular interstitium, as well 
as a better preservation of proximal tubular epithelial cells (assessed by lotus tetragonolobus [LTL] 
staining) (Fig. 2c). Intrarenal expression of COL I and FN was also analyzed by RT-qPCR. 
Significantly lower mRNA levels of these molecules were observed in the kidneys from CL-11-/- mice, 
compared to CL-11+/+ controls (Fig. 2d). Taken together, these observations demonstrate that CL-11 
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deficiency reduces accumulation of ECM and proximal tubule damage, which corresponds well with of 
a reduction in renal function impairment and histological scores described in figure 1.  
 
CL-11 is required for renal inflammatory cell infiltration, tissue inflammation and fibrogenesis 
following renal IR 
 
An influx of inflammatory cells is a hallmark of tubulointerstitial fibrosis. We therefore examined 
inflammatory cell infiltration in the kidneys of CL-11+/+ and CL-11-/- mice following the induction of renal 
IR injury using flow cytometry and immunohistochemistry. Flow cytometry analysis of renal cell 
suspensions showed that under normal conditions, there was no significant difference in basal levels 
of leukocytes between CL-11+/+ and CL-11-/- mice (data not shown). Following induction of renal IR 
injury, leukocyte infiltration increased in both groups of mice. However, CL-11-/- mice had significantly 
lower numbers of CD45+ (total leukocytes) in the kidneys at 2 and 7 days post-reperfusion, when 
compared to CL-11+/+ controls (Fig. 3a, 3b). As the infiltrating leukocytes (CD45+) in the kidney post-
reperfusion were mainly composed of Ly6G+ (neutrophil) and Ly6G-F4/80+ (monocyte/macrophage 
[MO/MΦ]), we further analyzed the infiltration of these two types of cells. CL-11-/- mice had lower 
numbers of both Ly6G+ (neutrophil) and Ly6G-F4/80+ (monocyte/macrophage [MO/MΦ]) in the injured 
kidneys, which was more clearly demonstrated at day 2 for neutrophil and day 7 for MO/MΦ (Fig. 3a, 
3b). Immunohistochemistry also demonstrated significantly lower numbers of CD45+, F4/80+ cells and 
Ly6G+ cells in CL-11-/- kidneys at 7 post-reperfusion compared with CL-11+/+ controls (Fig, 3c), in 
agreement with flow cytometry data. In addition, we assessed the effect of CL-11 on renal tissue 
inflammation and fibrogenesis following renal IR injury. Intrarenal gene expression of proinflammatory 
cytokines (TNF-α, IL-1β, IL-6), chemokines (CXCL1, CCL2) and profibrotic factors (TGF-β, PDGF) 
was significantly lower in CL-11-/- kidneys compared to CL-11+/+ controls at 7 days post-reperfusion 
(Fig. 4). These results together demonstrate that CL-11 is required for renal inflammatory cell 
infiltration, tissue inflammation and fibrogenesis following renal IR injury. 
 
CL-11 promotes leukocyte migration in vitro 
 
The association of CL-11 with renal inflammatory cell infiltration raises the question of whether CL-11 
has direct effect on leukocyte migration. It has been reported that several plant lectins such as 
concanavalin A (Con A) and peanut agglutinin can promote human neutrophil migration,26 in a 
carbohydrate-dependent manner. We speculated that CL-11 may have such function. We therefore 
performed a chemotaxis assay to evaluate the effects of CL-11 on leukocyte migration using murine 
peritoneal exudate cells (>80% neutrophil/MO/MΦ) and recombinant CL-11 (rCL-11). We first 
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characterized the rCL-11 by western blot. Under a reducing condition, rCL-11 displayed a (predicted) 
band with 34 kDa molecular weight, reflecting a monomeric unit of CL-11. This band was also 
detected in normal mouse serum (sFig. 1). We also checked and confirmed that the endotoxin levels 
in the working concentrations of rCL-11 used in our study are far below the reported lowest 
concentration of endotoxin (0.5 ng/mL) that showed effects in cell culture experiments, according to 
the company datasheet. Our chemotaxis results showed that rCL-11strongly induced leukocyte 
migration in a rCL-11 dose-dependent manner (150 ng/mL-1200 ng/mL) (Fig. 5a). Migration induced 
by rCL-11(600 ng/mL) was comparable to that induced by N-formyl-met-leu-phe (fMLP), a well-
described chemoattractant (100nM) (Fig. 5b), indicating the potency of CL-11 in chemotaxis. To 
assess the possibility that CL-11 mediates leukocyte migration through complement activation, we 
performed the chemotaxis assay using peritoneal exudate cells from C3-/- mice. Results showed that 
CL-11 significantly increased the migration of C3-/- leukocytes; the effect was comparable to that on 
WT leukocytes (Fig. 5c). We next explored the ligands which could be responsible for CL-11 mediated 
leukocyte migration. We initially examined the specificity and intensity of carbohydrate moieties in our 
murine leukocyte preparations by lectin-binding assay using several fluorescein labelled lectins: 
galanthus nivalis lectin (GNL) (for detection of terminal α (1,3) linked mannose residues), lens culinaris 
agglutinin (LCA) (for detection of branched fucose/α-linked mannose residues), lotus tetragonolobus 
(LTL) (for detection of terminal α-L-fucose and fucose alone) and ulex europaeus I (UEA I) (for 
detection of α(1,2) linked fucose residues). Flow cytometry analysis showed that GNL, LCA, LTL and 
UEA I were able to bind to murine leukocytes; markedly high binding intensities were observed with 
GNL and LCA, indicating predominant presence of mannosyl residues (Man) on the cell surface (sFig. 
2a). We then assessed whether blocking carbohydrate recognition of CL-11 by using its preferential 
monosaccharide ligands (L-fucose, D-mannose) could inhibit chemotactic effect of CL-11 on 
leukocytes. Pre-incubation of rCL-11 with D-mannose effectively reduced CL-11 mediated leukocyte 
migration. Pre-incubation with L-fucose led to a small reduction of the migration, but pre-incubation 
with a less preferred monosaccharide ligand (D-galactose) had no effect on CL-11 mediated leukocyte 
migration (Fig. 5d). These results demonstrate that CL-11 has a chemotactic effect on murine 
leukocytes, and the effect is carbohydrate-dependent.  
 
CL-11 stimulates renal fibroblast proliferation in vitro  
 
Renal interstitial fibroblasts are the key effector cells in the development of renal fibrosis. Plant lectins 
such as Con A are known to have stimulatory effects on hamster renal fibroblast proliferation.27 We 
therefore sought to investigate the possibility that CL-11 can stimulate renal fibroblast proliferation. To 
this end, we cultured primary renal fibroblasts from mice and confirmed that >95% were positive 
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for vimentin (sFig. 3). Proliferation assay was performed on the fibroblasts treated with rCL-11 and 
controls for 24h using Click-iT® EdU Alexa Fluor® 488 Imaging Kit. Initial experiments showed that 
treatment of fibroblasts with different concentrations of rCL-11 (in the range of 300-1200 ng/mL) 
significantly increased EdU-labelled cell numbers, with a maximal stimulation at 600 ng/mL (Fig. 6a). 
The stimulatory effect of CL-11 on fibroblast proliferation was further confirmed at the concentration of 
600 ng/mL, which is comparable to that stimulated by Con A at 1 µg/mL concentration (Fig. 6b, 6c). 
These results clearly demonstrate that CL-11 has stimulatory effects on renal fibroblasts. 
 
It has been shown that CL-11 preferentially binds to mannose-containing glycans.18 We therefore 
sought to investigate whether the effect of CL-11 on renal fibroblast proliferation is dependent on 
interaction with Man on renal fibroblast surface. We first examined the specificity and intensity of 
carbohydrate moieties on renal fibroblasts by using fluorescein labelled lectins. Flow cytometry 
revealed the high binding intensities of GNL and LCA and the low binding intensities of UEA-I and LTL, 
indicating predominant presence of Man on renal fibroblast surface (sFig. 2b). Fluorescence 
microscopy confirmed this by showing positive staining of GNL and LCA in renal fibroblasts (Fig. 6d). 
Using confocal microscopy, presence of Man on the cell surface also corresponded with CL-11 
binding (Fig. 6e). We then assessed wheth r blocking CL-11-Man interaction can inhibit the effect of 
CL-11 on renal fibroblast proliferation. Proliferation assay showed that prior treatment of renal 
fibroblasts with α-mannosidase significantly inhibited CL-11 mediated fibroblast proliferation, when 
compared with control treatment; but prior treatment with β-galactosidase did not affect CL-11 
mediated fibroblast proliferation (Fig. 6f). These observations support the concept that Man on the 
surface of renal fibroblasts is involved in CL-11-mediated fibroblast proliferation. 
 
Local production of CL-11 in the kidney plays an important role in the development of renal 
tubulointerstitial fibrosis 
 
CL-11 has relatively low serum concentrations (~300 ng/mL), compared to MBL (~2 µg/mL), and 
usually exists in the circulation as a dimeric or trimeric form (>200kD). When complexed with CL-10 in 
the circulation, it forms a large molecule (up to 800kD). These large molecules may not be able to 
penetrate into the interstitial space of organs including the kidney. Therefore, we hypothesized that 
local production of CL-11 within the kidney is important for the development of renal tubulointerstitial 
fibrosis. To test this, we performed syngeneic mouse kidney transplantation in the following 
combinations: i) CL-11-/- (donor) to CL-11+/+ (recipient), ii) CL-11+/+ (donor) to CL-11+/+ (recipient) and 
assessed donor renal tubular damage (by PAS staining) and collagen deposition (by Sirius red 
staining) at 7 days post-transplantation. CL-11-/- isografts displayed much less tubular damage and 
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collagen deposition than CL-11+/+ controls (Fig. 7). The extent of reduction in tubular damage and 
collagen deposition in CL-11-/- isografts was comparable to that observed in the kidneys of CL-11-/- 
mice (have a generalized CL-11 deficiency) following renal IR injury, indicating a predominant role for 
local production of CL-11 in this model.  
 
Discussion 
 
Our recent work in a murine model of acute renal IR injury has shown that AKI in the early phase is 
dependent on CL-11.21 It was proposed that CL-11 detects stress-induced L-fucose pattern on renal 
tubules to trigger complement activation that mediates renal tubular epithelial injury. In the present 
study, we extended our observations to the late phase of renal IR injury and examined the impact of 
CL-11 on renal chronic inflammation and fibrosis following renal IR. Overall, our data clearly 
demonstrate a pathogenic role for CL-11 in the progression of renal tubulointerstitial fibrosis, and 
suggest novel mechanisms for the pro-fibrotic effects of CL-11, namely the promotion of leukocyte 
migration and stimulation of renal fibroblast proliferation. 
 
A key observation from this study is that renal chronic inflammation and tubulointerstitial fibrosis are 
dependent on CL-11. We have shown that CL-11-/- mice are protected from deterioration of renal 
function, with attenuated renal chronic tissue inflammation (i.e. inflammatory cell infiltration, tubule 
injury, intrarenal synthesis of pro-inflammatory and pro-fibrotic molecules) and attenuated ECM 
accumulation in the tubulointerstitial space. In renal isografts, attenuated tubule damage and collagen 
deposition were only observed in CL-11-deificient kidneys. This observation gives rise to an intriguing 
question of how CL-11 contributes to chronic renal inflammation and tubulointerstitial fibrosis.  
 
In terms of the cellular mechanisms underlying this novel pathogenic role of CL-11 as a mediator of 
chronic renal inflammation and tubulointerstitial fibrosis, we have made two important in vitro 
observations. First, a potent effect of CL-11 on leukocyte (mainly neutrophil/MO/MΦ) migration was 
observed, indicating that CL-11 has chemotactic activity. Given that our leukocyte migration assays 
were performed in a serum-free condition and CL-11 had clear effects on leukocyte migration, in the 
absence of complement activation, the effect of CL-11 on leukocyte migration is likely to be 
complement-independent, thus suggesting CL-11 has a direct, complement-independent effect on 
leukocyte migration, which is consistent with reported roles for plant lectins in neutrophil migration 26 
and more recently for CL-11 in HeLa cell migration.19 In support of this complement-independent effect, 
our in vivo observations showed that although renal cellular infiltration was persistently lower in CL-11-
/- mice than that in CL-11+/+ mice at day 2 and day 7 post-reperfusion, complement activation in the 
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kidneys as measured by C3d deposition was not a prominent feature in the late phase of injury, which 
was also comparable between the WT and CL-11-/- mice (sFig. 4). Therefore, in addition to the 
proinflammatory action of CL-11 on tubular epithelial cells in the early phase of IR injury which triggers 
inflammatory responses (i.e. complement activation, cellular infiltration) to cause tubular injury, CL-11 
released from stressed or damaged tubular epithelial cells (or other cells) may function as a 
chemoattractant for leukocytes, promoting inflammatory cell infiltration, thereby exacerbating renal 
tissue inflammation and driving the profibrotic process. Secondly, renal fibroblast proliferation, a key 
cellular process directing renal fibrosis, was significantly enhanced by CL-11 stimulation, 
demonstrating an important role for CL-11 in renal fibroblast proliferation. Fibroblasts (e.g. from skin, 
synovial) are a known source of complement28, 29 and it is possible that binding of CL-11 may cause 
the cell activation via complement activation. However, CL-11-mediated complement activation does 
not appear to be prominent in our fibroblast culture system (sFig. 5), as there is no indication of 
complement deposition on renal fibroblasts following CL-11 stimulation, although the possibility of a 
complement-dependent effect in vivo cannot be excluded. Therefore, locally produced CL-11 may 
function as stimulator for renal fibroblast, promoting cell proliferation, thus contributing to the 
progression of tubulointerstitial fibrosis. 
 
Our observation on CL-11 promoting leukocyte migration and renal fibroblast proliferation in vitro 
raised the question of which ligands responsible for CL-11 mediating these cellular processes. L-
fucose, mannose and mannose-containing glycans have been suggested as preferential binding 
ligands for CL-1117, 18. In our previous study in acute renal IR injury, we proposed that CL-11 
recognizes stress associated L-fucose pattern on proximal tubular epithelial cells upon ischemic insult. 
This is based on the fact that L-fucose is exclusively and abundantly produced by proximal tubular 
epithelial cells and is a maker for this type of cells in the kidney, and our observation that a 
disorganized pattern of L-fucose was expressed and aligned with CL-11 in the basolateral border of 
the proximal tubules in ischemic kidneys. In this study, the flow cytometry and fluorescence 
microscopy confirm that Man are predominantly present on the cell surface of leukocytes and renal 
fibroblasts. With regard to the molecule(s) responsible for the action of CL-11 on leukocyte migration, 
our blocking experiments showed that pre-incubation of rCL-11 with D-mannose or L-fucose was able 
to block the effect of CL-11-mediated leukocyte migration, indicating the action is carbohydrate-
dependent. In support of this, previous studies have shown that neutrophil chemotaxis mediated by 
several plant lectins was effectively inhibited by pre-incubation of the lectins with their carbohydrate 
ligands.26 Furthermore, our lectin screening results revealed predominant expression of Man on 
leukocyte cell surface supporting that CL-11-mediated leukocyte migration is mainly through a Man 
recognition mechanism. With regard to the molecule(s) responsible for the action of CL-11 on renal 
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fibroblast proliferation, our study suggests that Man is also involved in CL-11-mediated cell 
proliferation. This is supported by our findings that CL-11 binds to Man on the fibroblast cell surface 
and removal of mannose (using α-mannosidase), but not galactose (using β-galactosidase) abrogates 
the effects of CL-11 on the fibroblast proliferation.  
 
Predominant presence of Man on the cell surface of leukocytes and renal fibroblasts raises possibility 
of that other collectins (e.g. MBL, SP-A) could play similar roles as CL-11 in these cellular processes, 
thus participating in the pathogenesis of renal fibrosis 
 
Renal inflammation is an initial protective response to kidney injury. However, excessive inflammatory 
responses in the kidney upon injury or unresolved renal inflammation are thought to be an important 
driver of the process of the fibrosis.9 This notion is further supported by our in vitro observations that 
supernatants, resulting from co-cultures of inflammatory cells (murine peritoneal exudate cells) with 
tubular debris, contained high levels of pro-inflammatory cytokines (TNF-α, IL-1β, and TGF-β) and 
were able to stimulate renal fibroblast proliferation (sFig. 6). Therefore, CL-11-mediated acute kidney 
injury (tubule damage, cellular infiltration), as a consequence of complement activation, would also 
stimulate the process of tubulointerstitial fibrosis. In agreement with this, C3-/- mice which have intact 
CL-11 also displayed less collagen deposition in the peritubular interstitium and cellular infiltration in 
the kidney on day 7 post-reperfusion (sFig. 7). Thus, there is a possibility that collectin-11 may be 
causing fibrosis in vivo, at least partly, through the earlier activation of complement. 
 
Based on our findings in this study and our published data in the study of acute injury,21 we propose 
that CL-11 contributes to chronic renal inflammation and tubulointerstitial fibrosis through three 
pathways: namely i) by stimulating renal fibroblast proliferation, ii) by mediating influx of inflammatory 
cells, iii) by triggering complement activation that increases renal tissue inflammation and fibrogenesis 
(Fig. 8).  
 
In conclusion, this study is the first to demonstrate a pathogenic role for CL-11 in the development of 
kidney fibrosis, and describes novel cellular and molecular mechanisms for CL-11 that contribute to 
progression of tubulointerstitial fibrosis, thus opening new avenues for studying the roles of CL-11 in 
renal fibrosis mediated by other causes and supporting therapeutic blocking the CL-11-ligand 
interaction in tubulointerstitial fibrosis. 
 
 
 
Page 10 of 42
ScholarOne support: 888-503-1050
Journal of the American Society of NEPHROLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
11 
 
Materials and Methods 
 
Reagents 
The following reagents were used in the current study: Infinity Urea (655870, Fisher Diagnosis, 
Virginia, USA); rat monoclonal anti-F4/80 Ab (ab16911), rabbit polyclonal anti-collagen 1 Ab 
(ab34710), rabbit polyclonal anti-fibronectin Ab (ab2413), rabbit monoclonal anti-vimentin Ab 
(EPR3776) (ab92547) (all are from Abcam, Cambridge, UK); TRITC-conjugated goat anti-rabbit IgG 
Ab (T6778, Sigma, Missouri, USA); rat monoclonal anti-CD45 Ab (MCD4500; Caltag Laboratories, 
California, USA); rat monoclonal anti-Ly-6B.2 Ab (MCA771G, Bio-Rad antibodies, Oxfordshire, UK); 
HRP-conjugated rabbit anti-rat Ig Ab (P0450; DAKO); APC rat anti-mouse CD45 Ab (103112), PE rat 
anti-mouse Ly-6G Ab (127607),  FITC rat anti-mouse F4/80 Ab (123108) and PE/Cy7 rat anti-mouse 
Ly-6C Ab (128018)  (all are from Biolegend, London, UK); Rabbit polyclonal anti-human C3d Ab 
(A0063; DAKO, Glostrup, Denmark); FITC-conjugated goat anti-rabbit IgG Ab (111-095-144; Jackson 
Immuno Research Lab., West Grove, USA); rabbit polyclonal anti-human CL-11 (abx003772; Abbexa 
Ltd, Cambridge, UK); donkey anti-rabbit Alexa Fluor 594 (406418; Biolegend, London, UK); 4',6-
diamidino-2-phenylindole (DAPI), Alexa 488 phalloidin (A12379), CountBright™ absolute counting 
beads (C36950) (all are from Life Technologies, Paisley, UK); recombinant CL-11 (rCL-11, C7549-85; 
USBiological, Massachusetts, USA); Fluorescein labelled Ulex Europaeus I (UEA-I) (FL-1061), 
Fluorescein labelled Lotus Tetragonolobus Lectin (LTL) (FL 1321), Fluorescein labelled Lens Culinaris 
Agglutinin (LCA) (FL-1041), Fluorescein labelled Galanthus Nivalis Lectin (GNL) (FL-1241),(all are 
from Vector laboratories, Peterborough, UK); D-(+)-Mannose (M6020), L-(-)-Fucose (F2262), D-(+)-
Galactose (G0750), α-mannosidase (M7257), β-glactosidase (G5635) (all are from Sigma, Missouri, 
USA); Mouse TNFα (555268) and IL-1β (559603) ELISA sets (BD Bioscience, San Jose, USA); Click-
iT® EdU Alexa Fluor® 488 Imaging kit (C10337; Thermo Fisher Scientific, Paisley, UK);  
Thioglycollate (CM0023, Oxoid, Hampshire, UK); collagenase II (LS004176, Worthington on 
Biochemical corporation, USA). 
  
Mice 
Homozygous CL-11-/- mice on a C57BL/6 background were purchased from Mutant Mouse Resource 
and Research Centers (MMRRC) (UC Davis, Davis California, USA) 30 and have been back crossed 
onto the C57BL/6 strain for 6 generations . WT littermates (CL-11+/+) were used as controls. Male mice 
(8-12 weeks) were used in all the experiments, unless specified. Animal procedures adhered to the 
Animals (Scientific Procedures) Act of 1986. 
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Induction of renal IR injury  
Renal IR injury was induced as we previously described with some modifications. 31 In brief, mice were 
anesthetized by isoflurane and kept warm on a heated pad. A midline abdominal incision was made. 
The renal arteries and veins were isolated and bilaterally occluded for 30 min with micro aneurysm 
clamps. After removal of the clamps, 0.5 ml of warm saline was put in the abdomen and the incision 
was sutured. Blood samples were taken at day 2 (tail bleeding) and day 7 (cardiac puncture) after 
reperfusion for renal function assessment. Kidneys were harvested at day 7 for histopathology, flow 
cytometry and RT-qPCR.  
 
Assessment of renal function, pathology and fibrosis 
Renal function was assessed by measuring the blood urea nitrogen (BUN) in the serum using a 
standard urease kit called Infinity Urea. Renal histopathological changes and fibrosis were assessed 
as described previously.32 In brief, kidneys were fixed with 4% formaldehyde in PBS for 48 hours and 
embedded in paraffin. Paraffin sections (2~4 µm) were stained with periodic acid-Schiff (PAS) stain, or 
Sirius red. Stained kidney sections were scanned with a Hamamatsu Nanozoomer 2.0 HT slide 
scanner (Hamamatsu Photonics, Hamamtsu, Japan) and viewed using NDP.view2 software. Renal 
histopathological changes were assessed on PAS–stained sections using a 6-point scale in which 0, 1, 
2, 3, 4, and 5 indicated normal, very little, very mild, mild, moderate, and severe histological lesions, 
respectively, as previous description.32 The assessment was based on histopathological changes (i.e. 
cellular infiltration, loss of proximal tubule brush border, tubule necrosis, tubule atrophy) that were 
mainly located at the cortical medullary junction area. Five viewing fields (0.49 mm2/field) from each 
kidney were examined. Renal fibrosis was assessed on Sirius red–stained sections. The positively 
stained areas were quantified by imaging analysis (ImageJ software; National Institutes of Health, 
Bethesda, MD, USA). Briefly, 6 to 8 viewing fields from the cortical medullary junction of each kidney 
were examined. Positively stained areas were expressed as a percentage of the whole field area (0.49 
mm2). All the aforementioned quantitative analyses were performed in a blinded fashion by 2 
experienced persons. 
 
Immunohistochemistry 
Immunohistochemistry was performed on frozen sections (~4 µm) of kidneys. For the detection of 
inflammatory cells, kidney sections were fixed in acetone and blocked by 10% rabbit serum, then 
incubated with rat anti-mouse CD45, Ly-6B.2, and F4/80 antibodies, respectively, at 4°C overnight and 
followed by HRP-conjugated rabbit anti-rat polyclonal antibody. The sections were scanned with a 
Hamamatsu Nanozoomer 2.0 HT slide scanner. Four fields (0.12 mm2 per field) in the cortical 
medullary junction of each kidney were randomly examined and the positively stained cells were 
Page 12 of 42
ScholarOne support: 888-503-1050
Journal of the American Society of NEPHROLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
13 
 
counted. The quantitative analysis was performed in a blinded fashion by two experienced persons. 
For the detection of extracellular matrix deposition, kidney sections were incubated overnight at 4°C 
with donkey anti-mouse collagen 1, fibronectin, and vimentin, respectively, and followed by TRITC-
conjugated goat anti-rabbit IgG Ab, DAPI (staining nuclei) and LTL (staining proximal tubules). The 
staining was examined via an A1R point scanning confocal microscope (Nikon, Japan) or an Olympus 
BX51 microscope (Japan).  
 
Assessment of inflammatory cell infiltration in the kidney  
Single renal cell suspensions were prepared using a method described previously.32 Kidneys were 
weighed, minced and incubated with collagenase D (0.75 mg/mL) for 10 min at 37°C with gentle 
agitation. The collagenase was inactivated with an equal volume of DMEM-F12 containing 10% FCS. 
The digested tissue mixture was then passed through a 40µm nylon sieve to remove tissue debris. 
The cell segments were collected and treated with red cell lysis buffer to remove remaining RBC. The 
cell pellet was washed and re-suspended in PBS containing 1% BSA and followed by flow cytometric 
analysis. The cells were pre-incubated with FcR blocking antibody (CD16/32), and then stained with 
rat anti-mouse APC-conjugated CD45, PE-conjugated Ly6G and FITC-conjugated F4/80 antibodies, 
or the appropriate isotype control antibodies at 4°C for 20 min. In order to quantify absolute cell counts 
in kidney tissue, we used CountBright™ absolute counting beads in our flow cytometry assays, 
according to the manufacturer’s instructions. All flow cytometric analysis was performed using Calibur 
Flow Cytometer (BD Biosciences) and Flowjo software (Tree Star, OR, USA). 
 
Reverse Transcription Quantitative PCR (RT-qPCR) 
Total RNA extraction from kidney tissue and cells and reverse transcription reaction were performed 
as previously described.33 qPCR was performed with a DyNAmo HS SYBR Green qPCR kit and an 
MJ Research PTC-200 Peltier Thermal Cycler (Bio-Rad) according to the manufactures’ instructions. 
Each sample was amplified in duplicates. The relative gene expression was analyzed using the 2-∆∆CT 
method 34 and expressed as 2-∆∆ (Ct), where Ct is cycle threshold, ∆∆ (Ct) = testing samples ∆ (Ct) - 
control samples ∆ (Ct); ∆ (Ct) = testing gene (Ct) -18s (Ct). The control samples were normal CL-11+/+ 
kidneys and the testing samples were injured kidneys. The primer sequences and size are shown in 
the supplemental table 1. 
 
Chemotaxis assay 
Chemotaxis assay was performed with murine peritoneal exudate cells (>80% neutrophil/MO/MΦ) 
which were prepared from peritoneal lavage of C3-/- or CL-11 WT mice 1 day after i.p. injection of 1 mL 
of 3% thioglycollate using a disposable 96-well cell migration system (106-3; Neuro Prob). 30 µl of cell 
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culture medium (RPMI 1640 with1% BSA) (negative control) or the medium containing rCL-11 (150-
1200ng/mL) or fMLP (100 nM) (positive control) were added to each chamber well. The framed filters 
with 3 µm pore size were placed to chamber wells and 50 µL of cell suspension (2x105 cells in RPMI 
1640 with1% BSA) were add to the top of each filter. The chamber was incubated for 1.5 hours at 
37°C with 5% CO2. The cells migrated to the bottom of each well were collected and stained with 
trypan blue and counted under microscope. In some experiments, rCL-11 (600 ng/mL) was pre-
incubated with 2.5 mM of D-mannose, L-fucose or D-galactose for 1 hour at room temperature in the 
presence of 2 mM Ca2+ and then added to the lower chamber wells. 
 
Mouse renal fibroblast culture 
Primary renal fibroblast culture was prepared from kidneys of CL-11+/+ mice as described previously 
with some modifications.35 In brief, the renal capsule was peeled off and a longitudinal incision was 
made on the kidney. The sections of cortex were carefully cut off and diced into mince. They were 
digested with 0.1% collagenase II in DMEM/F-12 medium for 20 min and passed through 250 µm, 106 
µm, and 75 µm metal sieves and a 40 µm nylon sieve. The unfiltered tubular debris on the nylon sieve 
was collected and treated macrophages for the study of cytokine expression described below. The 
filtered cells were cultured in DMEM/F-12 medium containing 10% FCS and 100 U/ml penicillin and 
100 µg/ml streptomycin. They experienced at least three passages to eliminate contaminated 
epithelial cells. Finally, the pure fibroblasts exhibited an elongated, spindle-shaped morphology with 
vimentin positive staining in immunohistochemistry.  
 
Proliferation assay 
Mouse renal fibroblasts were seeded on 1% gelatin-coated 8 mm cover glass in a 48-well plate with 
3x104 cells per well. They came to 70-80% confluence after 2 days of culture. The cells were 
incubated in the medium only (DMEM/F-12 with 5% FCS) or the medium containing different 
concentrations of rCL-11 (300-1200 ng/mL) or Con A (1 µg/mL) for 24 h. In some experiments, cells 
were pre-incubated with or without 5 mM α-mannosidase or β-galactosidase diluted in glycol buffer 3 
and DMEM/F-12 for 1 hour at 37°C. After three washes in PBS, the cells were continued to treat with 
600 ng/mL rCL-11 for 24 h. At the end of rCL-11 treatment, cells were incubated with serum-free 
DEME/F-12 containing 10 mM EdU for 2 h and fixed in 3.7% formaldehyde. Incorporated EdU was 
detected by a Click-iT® EdU Alexa Fluor® 488 Imaging kit according to manufacturer’s instructions. 
Pictures were taken by an Olympus BX51 microscope. The DAPI-positive nuclear (representing the 
total cell number) and EdU positive nuclear (representing the proliferating cell number) were counted 
using Image J. The proliferation rate was calculated using the following formula: proliferation rate = 
(EdU positive nuclear number/DAPI positive nuclear number) x 100%. 
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Detection of mannosyl residues in renal fibroblasts  
The mouse renal fibroblasts were fixed in 4% PFA for 15 min (without permeablization) and stained 
with DAPI and fluorescein-labelled GNL and LCA for 1 hour at room temperature. Pictures were taken 
with an A1R point scanning confocal microscope. 
 
Detection of CL-11 binding to renal fibroblasts 
the renal fibroblasts cultured from CL-11-/- mice were incubated with rCL-11 (600 ng/mL) for 24 h and 
fixed in 4% PFA for 15 min. Without cell membrane permeablization, the cells were blocked with 10% 
donkey serum and incubated with rabbit anti-human CL-11 antibody overnight at 4°C, followed by the 
secondary donkey anti-rabbit Alexa Fluor 594 antibody, fluorescein-labelled GNL or LCA and DAPI for 
1 hour at room temperature. The staining was examined via an A1R point scanning confocal 
microscope. 
 
Mouse kidney transplantation 
Kidney transplants were performed in mice as previously described.21 Briefly, mice were anesthetized 
with isoflurane (Abbott Laboratories). Donor kidney along with the ureter was harvested, including the 
renal artery with a small aortic cuff and the renal vein. These vascular cuffs were anastomosed to the 
recipient abdominal aorta and vena cava, respectively, below the level of the native renal vessels. 
Total ischemic time was about 35 min. The donor ureter was connected to the recipient bladder. The 
right native kidney was removed before the vascular anastomosis. The transplanted kidney was 
collected 7 days after surgery. PAS and Sirius red staining were performed to assess tissue damage 
and renal fibrosis.  
 
Statistics 
Data are shown either as mean ± SEM or the readout for individual mice. An unpaired, 2-tailed 
Student’s t test was used to compare two groups. A P value less than 0.05 was considered significant. 
One-way ANOVA was used for comparisons between three or more groups. All analyses were 
performed using Graph Pad Prism Version 5 (Graph Pad Software).  
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Figure 1. Deficiency of CL-11 reduces tubule damage and renal function impairment in the late 
phase of renal IR. (a) BUN levels in CL-11+/+ and CL-11-/- mice at day 2 and day 7 post renal 
ischemia (30 min) reperfusion. Data were analysed by two-way ANOVA. Dashed line represents the 
BUN level in normal mice. (b) Representative images of PAS staining on kidneys of CL-11+/+ and CL-
11-/- mice at day 7 post renal ischemia reperfusion, taken at the cortical-medullary junction. Arrows 
indicate injured tubules. Scale bars: 100 µm. (c) Histological scores for renal tubular injury in the mice 
illustrated in b. Data were analysed by Unpaired two-tailed Student’s t test. ****, P<0.0001. (a, c): each 
dot represents an individual mouse and a representative of two independent experiments is shown. 
 
Figure 2. Deficiency of CL-11 reduces accumulation of ECM in the kidney following renal IR. (a) 
Representative images of Sirius red staining on kidneys of CL-11+/+ and CL-11-/- mice at day 7 post 
renal ischemia reperfusion, taken at the cortical-medullary junction. Scale bars: 100 µm. Arrows 
indicate positive stained arears. (b) Quantification of Sirius red stained arears corresponding to the 
CL-11+/+ and CL-11-/- mice in a. Data were analysed by Unpaired two-tailed Student’s t test (n=35-50 
viewing fields from 7-9 mice/group), ***, P<0.0001. (c) Extracellular matrix protein (ECM) deposition in 
kidneys. Left panels, representative fluorescence microscope images of collagen I (red), fibronectin 
(red), vimentin (red), lotus tetragonolobus lectin (LTL) (a proximal tubular marker) (green), DAPI (blue) 
staining on kidneys of CL-11+/+ and CL-11-/- mice at day 7 post renal ischemia reperfusion, taken at the 
cortical-medullary junction. Arrows indicate positive stained arears. Scale bars: 20 µm. Right panels, 
quantification of positively stained arears of collagen I, fibronectin and vimentin, corresponding to the 
CL-11+/+ and CL-11-/- mice in left panels. Data were analysed by Unpaired two-tailed Student’s t test 
(n=6 viewing fields from 2 mice/group). ***, P<0.001. (d) Relative mRNA levels of collagen I (Col I) 
and fibronectin (FN) in kidneys of CL-11+/+ and CL-11-/- mice at day 7 post renal ischemia reperfusion, 
determined by RT-qPCR. Data were analysed by Unpaired two-tailed Student’s t test (n=6-7 mice per 
group). Each dot represents an individual mouse. *, P<0.05; **, P<0.01. 
 
Figure 3. Deficiency of CL-11 reduces renal leukocyte infiltration following renal IR. (a, b) Renal 
inflammatory cell infiltration in CL-11+/+ and CL-11-/- mice at day 2 and day 7 post renal ischemia 
reperfusion, determined by flow cytometry. (a) Stepwise gating strategy used in flow cytometric 
analysis leukocytes (CD45+), neutrophils (Ly6G+) and macrophages (F4/80+). (b) Quantification of 
leukocytes (CD45+), neutrophils (CD45+Ly6G+) and macrophages (CD45+F4/80+). Data were analysed 
by Unpaired two-tailed Student’s t test (n=4 mice per group). *, P<0.05; **, P<0.01. Each dot 
represents an individual mouse. (c) Renal inflammatory cell infiltration in CL-11+/+ and CL-11-/- mice at 
day 7 post renal ischemia reperfusion, determined by immunohistochemistry. Left panels: 
representative images of immunochemical staining for CD45, Ly6G and F4/80 in kidneys of CL-11+/+ 
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and CL-11-/- mice. Scale bars: 50 µm. Right panels: quantifications of CD45+, Ly6G+ and F4/80+ cells 
in kidneys of CL-11+/+ and CL-11-/- mice. Data are shown as mean ± SEM (n=31-45 viewing fields from 
7-9 mice/group) and were analysed by Unpaired two-tailed Student’s t test ***, P<0.0001. (a-c) A 
representative of two independent experiments is shown. 
 
Figure 4. Deficiency of CL-11 reduces renal tissue inflammation and fibrogenesis following 
renal IR. Relative mRNA levels of pro-inflammatory (a) and pro-fibrogenic factors (b) in the injured 
kidneys of CL-11+/+ and CL-11-/- mice at day 7 post renal ischemia reperfusion, determined by RT-
qPCR. Data were analyzed by Unpaired two-tailed Student’s t test, except for the PDGF that was 
analysed by Mann Whitney test (n=8 mice/group). Each dot represents an individual mouse. *, P<0.05; 
***, P<0.001. 
 
Figure 5. CL-11 promotes leukocyte migration in vitro. (a) Cell migration in response to medium 
(Ctrl), medium containing different concentrations of recombinant CL-11 (rCL-11). (b) Cell migration in 
response to medium (Ctrl), medium containing rCL-11 (600 ng/ml) or N-formyl-met-leu-phe (fMLP) 
(100 nM). (a, b) Data were analysed by One-way ANOVA with Tukey’s post-test (n=5 per group). (c) 
Cell migration in response to medium (Ctrl) and medium containing rCL-11 (600 ng/ml) in C3 KO and 
CL-11 WT leukocytes. (d) Cell migration in response to rCL-11 (600 ng/ml) (rCL-11) or rCL-11 (600 
ng/ml) that had been pre-incubated with D-(+)-mannose (Man), L-(-)-fucose (Fuc) or D-(+)-galactose 
(Gal) (all at 2.5mM). (c, d) Data were analysed by One-way ANOVA with Tukey’s post-test (n=5-19). 
(a-d) representative of at least 3 independent experiments. *, P<0.05. **, P<0.005. ***, P<0.001. 
 
Figure 6. CL-11 stimulates renal fibroblast proliferation and ECM production. (a) Proliferation 
rate of renal fibroblasts without or with different concentrations of CL-11. Data were analyzed by One-
way ANOVA (n=6 viewing fields from 2 cell samples/group). ***P<0.0001. (b) Representative 
fluorescent images of EdU-labelled renal fibroblasts without or with rCL-11 (600 ng/ml) and 
Concanavalin A (Con A, 1 µg/ml) treatment. Scale bars: 50 µm. (c) Quantification of EdU-labelled 
renal fibroblasts, corresponding to the fibroblasts in b and expressed as proliferation rate. Data were 
analysed by One-way ANOVA with Tukey’s post-test (n=8 viewing fields from 2 cover glass/group). 
*P<0.05. **P<0.005. (b, c) A representative of 3 independent experiments is shown. (d) Fluorescence 
microscopy images of LCA (green), GNL (green) and DAPI (blue) staining in renal fibroblasts. Scale 
bars: 10 µm. (e) Representative confocal image of 2 independent experiments showing renal 
fibroblasts (from CL-11-/- mice) that had been incubated with rCL-11 (600ng/ml) for 24h and subjected 
to staining for CL-11 (red) and LCA (green) and nuclear marker DAPI (blue). Scale bars: 10 µm. (f) 
Proliferation rate of renal fibroblasts that had been pre-treated with buffer alone (Ctrl) or buffer 
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containing α-mannosidase (5 mM) or β-galactosidase (5 mM), and followed by incubation with rCL-11 
(600 ng/ml). Data were analyzed by One-way ANOVA with Tukey’s post-test (n=8 viewing fields from 
2 cover glass/group). **P<0.005.  
 
Figure 7. Kidney-specific deficiency of CL-11 protects against the development of 
tubulointerstitial fibrosis. Histological injury and renal fibrosis are shown for CL-11+/+ mice 
transplanted with kidneys from CL-11+/+ or CL-11-/- littermates. Kidney grafts were collected 7 days 
after transplantation. Pictures were taken at the cortical-medullary junction. (a) Left panel: 
representative images of PAS staining. Arrows illustrate injured tubules. Scale bars: 50 µm. Right 
panel: histological scores for renal tubular injury in the mice. Data were analysed by Unpaired two-
tailed Student’s t test (n=49-60 viewing fields from 7-8 mice/group, 0.49mm2 per viewing field). ***, 
P<0.001. (b) Left panel: representative images of Sirius red staining. Arrows show collagen deposition. 
Scale bars: 50 µm. Right panel: quantification of Sirius red stained arears. Data were analysed by 
Unpaired two-tailed Student’s t test (n=22-32 viewing fields from 3-4 mice/group). *, P<0.05. 
 
Figure 8. Proposed mechanism by which CL-11 contributes to renal tubulointerstitial fibrosis. 
Based on our findings in this study and our published data in the study of acute injury, we propose that 
local production of CL-11 (by renal tubular epithelial cells and possibly by other cells) is upregulated 
by renal ischemia reperfusion. Locally produced CL-11: i) stimulates renal interstitial fibroblasts and 
causes cell proliferation and ECM production, ii) mediates influx of inflammatory cells into the kidney, 
these inflammatory cells produce pro-inflammatory and pro-fibrotic factors in response to debris 
stimulation, which increase tissue inflammation and fibrogenesis, iii) detects stress-induced L-fucose 
pattern on renal tubules to trigger complement activation that mediates renal tubular epithelial injury 
and production of pro-inflammatory and pro-fibrotic factors by tubular epithelial cells, which increase 
renal tissue inflammation and fibrogenesis.  
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Figure 1. Deficiency of CL-11 reduces tubule damage and renal function impairment 
in the late phase of renal IR  
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Figure 3. Deficiency of CL-11 reduces renal leukocyte infiltration following renal IR  
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Figure 4. Deficiency of CL-11 reduces renal tissue inflammation and fibrogenesis  
following renal IR 
a 
TGF-
CL-11+/+ CL-11-/-
0
1
2
3
4
5
***
R
e
la
ti
v
e
 e
x
p
re
s
s
io
n
 o
f 
m
R
N
A
PDGF
CL-11+/+ CL-11-/-
0
2
4
6
8
10
*
TNF
CL-11+/+ CL-11-/-
0
2
4
6
***
R
e
la
ti
v
e
 e
x
p
re
s
s
io
n
 o
f 
m
R
N
A
IL-1
CL-11+/+ CL-11-/-
0
5
10
15
*
IL-6
CL-11+/+ CL-11-/-
0
5
10
15
20
25
*
CXCL1
CL-11+/+ CL-11-/-
0
10
20
30
40
50
60
70
*
CCL2
CL-11+/+ CL-11-/-
0
20
40
60
80
100
***
b 
Page 26 of 42
ScholarOne support: 888-503-1050
Journal of the American Society of NEPHROLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Figure 5. CL-11 promotes leukocyte migration in vitro 
a 
C tr l 1 5 0 3 0 0 6 0 0  1 2 0 0  
0
1
2
3
4
5
rC L -1 1  (n g /m l)
C
h
e
m
o
ta
x
is
 i
n
d
e
x P < 0 .0 0 0 1
b 
C tr l rC L -1 1 fL M P
0
1
2
3
4
C
h
e
m
o
ta
x
is
 i
n
d
e
x
* * *
* * *
600
(n g /m l)
100
(nM )
c 
0
1
2
3
C trl
rC L -1 1
C 3  K O C L -1 1  W T
* *
* * *
C
h
e
m
o
ta
x
is
 i
n
d
e
x
d 
0
1
2
3
M an F u c G al
*
rC L -1 1  p re -in c u b a te d  w ith
C
h
e
m
o
ta
x
is
 i
n
d
e
x
rC L -1 1
Page 27 of 42
ScholarOne support: 888-503-1050
Journal of the American Society of NEPHROLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Figure 6. CL-11 stimulates renal fibroblast proliferation and ECM production  
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Figure 7. Kidney-specific deficiency of CL-11 protects against the development of 
tubulointerstitial fibrosis  
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sFigure 1. Western blot analysis of rCL-11 and CL-11 WT mouse serum.
sFigure 1. Western blot analysis of rCL-11 and CL-11 WT mouse serum.
rCL-11 (0.1 µg and CL-11 WT mouse serum (80 µg) were run in SDS-PAGE
under a reducing condition, followed with western blot by using polyclonal goat
anti-human COLEC11 Ab (1:300, Sant Cruz) and rabbit anti-goat HRP Ab
(1:1000, Dako).
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sFigure 2. Leukocytes and renal fibroblasts express a great amount of mannose 
moieties on the cell surface
sFigure 2. Leukocytes and renal fibroblasts express a great amount of
mannosyl residues on the cell surface. Peritoneal exudate cells (collected 24h
after intraperitoneal injection of 1 ml of 3% thioglycollate) and renal fibroblasts were
incubated without or with fluorescein labelled lectins, including Ulex Europaeus I
(UEA-I), Lotus Tetragonolobus Lectin (LTL), Galanthus Nivalis Lectin (GNL) and
Lens Culinaris Agglutinin (LCA), for 30 min and processed for flow cytometry. (a)
histogram and quantification (shown as geometric mean of fluorescence intensity,
GMFI) of the four lectins binding to peritoneal exudate cells. (b) histogram and
quantification of the four lectins binding to renal fibroblasts.
a
b
Control UEA-I LTL GNL LCA
0
10
20
30
300
400
500
600
700
800
G
M
FI
Fluorescence intensity
Ev
en
ts
 
(%
 
o
f m
ax
) Control
UEA-I
LTL
GNL
LCA
Leukocytes
Control LTL UEA-I GNL LCA
0
5
10
15
500
1000
1500
G
M
FI
Fluorescence intensity
Ev
en
ts
 
(%
 
o
f m
ax
) Control
UEA-I
LTL
GNL
LCA
Renal fibroblasts
Page 33 of 42
ScholarOne support: 888-503-1050
Journal of the American Society of NEPHROLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Vimentin staining
sFigure 3. Characterisation of cultured renal fibroblasts by vimentin staining
sFigure 3. Characterisation of cultured renal fibroblasts by vimentin staining.
Representative fluorescence microscopy images of CL-11-/- renal fibroblast cells (of
2 independent experiments) that had been stained for vimentin (green) and nuclear
marker DAPI (blue). Negative control was performed using the 2nd antibody alone.
Scale bars: 20 µm.
Negative control
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sFigure 4. Deficiency of CL-11 does not influence C3d deposition in day 7 post-
ischemic kidneys. 
a
b
sFigure 4. Deficiency of CL-11 does not influence C3d deposition in day 7 post-
ischemic kidneys. (a) Representative images of immunofluorescence staining of C3d in
kidneys of normal CL-11+/+ mice and ischemic CL-11+/+ and CL-11-/- mice at day 7 post
renal ischemia reperfusion. (b) Quantifications of C3d in kidneys corresponding to the mice
represented in a. Data are shown as mean ± SEM and were analysed by One-way
ANOVA with Tukey’s post-test (n=20 viewing fields from 4 mice/group). *, P<0.05; **,
P<0.001; ns, no significant. Scale bars: 20 µm.
CL-11+/+ Ischemic CL-11-/- IschemicCL-11+/+ Normal
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sFigure 5. Detection of C3d deposition in renal fibroblast cultures
sFigure 5. Detection of C3d deposition in renal fibroblast cultures. Fluorescence
microscopy images of immunochemical staining of C3d (green) and DAPI (blue) in
renal fibroblasts cultured from CL-11-/- mice. Cells were incubated with recombinant CL-
11 (rCL-11, 600ng/ml) for 48 h or 20% CL-11+/+ mouse serum for 30 min, followed by
fixation with 4% paraformaldehyde. They were then stained with rabbit polyclonal anti-
human C3d and goat anti-rabbit Alexa Fluor 488. (a) Renal fibroblasts treated with rCL-
11. (b) Renal fibroblasts treated with 20% CL-11+/+ mouse serum. Scale bars: 20 µm.
a b
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sFigure 6. Tubular debris stimulates macrophages to secrete pro-
inflammatory factors and subsequently increases fibroblast proliferation
a b
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c
sFigure 6. Tubular debris stimulates macrophages to secrete pro-inflammatory factors,
which increase fibroblast proliferation. Peritoneal exudate cells, mainly macrophages, were
collected from CL-11+/+ mice 3 days after intraperitoneal injection of thioglycollate. They were
incubated without or with tubular debris (200 ng/ml or 1000 ng/ml) for 24 h. Half of supernatants
were used to measure TNF-α and IL-1β concentrations by ELISA. The other half was incubated
with renal fibroblasts for 2 days and followed by EdU labelling. (a, b) TNF-α and IL-1β levels.
Data are shown as mean ± SEM and were analysed by One-way ANOVA (n=4 per group), by
comparing the control and renal tubular debris stimulated. (c) Counting of EdU-positive cells.
Data are shown as mean ± SEM and were analysed by Unpaired two-tailed Student’s t test (n=4
per group). ***, P<0.0001. (a-c) A representative of 2 individual experiments is shown.
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sFigure 7: Renal fibrosis and tubule damage in C3-/- and C3+/+ mice following IR
injury
C3+/+ C3-/-
SR
PAS
sFigure 7: Renal fibrosis and tubule damage in C3-/- and C3+/+ mice following IR
injury. Representative images of Sirius red and PAS staining in C3+/+ and C3-/- mouse
kidneys at day 7 post renal ischemia (30 min) reperfusion injury, taken at the cortical
medullary junction. Arrows indicate positive stained arears and injured tubules. Scale
bars: 100 µm.
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1
Supplementary Table 1 
PCR primer sequences and product sizes 
 
Primer* Oligonucleotide Sequence 
(5’ → 3’) 
Product 
Size (bp) 
Gene bank code  
18S-1 ATC CCT GAG AAG TTC CAG CA 153 NM_011296.1 
18S-2 CCT CTT GGT GAG GTC GAT GT  
TNF-α-1 
TNF-α-2 
TGA GCA CAG AAA GCA TGA TCC 
GCC ATT TGG GAA CTT CTC ATC 
200 NM_013693.3 
IL6-1 
IL6-2 
GTT CTC TGG GAA ATC GTG GA 
GGA AAT TGG GGT AGG AAG GA 
339 NM_031168 
CXCL1-1 TGA AGC TCC CTT GGT TCA GA 361 NM_008176.3 
 CXCL1-2 TGC ACT TCT TTT CGC ACA AC  
CCL2-1 
CCL2-2 
GGC TCA GCC AGA TGC AGT TA  
ATT TGG TTC CGA TCC AGG TT 
219 NM_011333.3 
 
TGF-β-1 AAT ACG TCA GAC ATT CGG GAA  640 NM_011577 
TGF-β-2 CCG GGT TGT GTT GGT TGT AGA G   
PDGF-1 
PDGF-2 
TAT GAA ATG CTG AGC GAC CA 
GAT CGA TGA GGT TCC GAG AG 
250 ENSMUST000000
00500 
Collagen I -1 
Collagen I -2 
TGA CTG GAA GAG CGG AGA GT 
GTT CGG GCT GAT GTA CCA GT 
151 OTTMUST000000
04184 
Fibronectin-1 
Fibronectin-2 
GAA GTC GCA AGG AAA CAA GC 
GCA TCG TAG TTC TGG GTG GT 
393 NM_010233 
 
* Primer-1 is identical to the coding strand; primer-2 is complementary to the coding strand.  
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Collectin-11 is required for the development of  
renal tubulointerstitial fibrosis  
RESULTS 
CL-11 deficiency reduced collagen deposition in the peritubular interstitium  and 
tubule damage.  
METHODS 
Bilateral renal ischemia reperfusion 
injury was induced in CL-11+/+ and CL-
11-/- mice and tubulointerstitial fibrosis 
was assessed by evaluation of  
collagen deposition and tubule 
damage 7 days later.   
doi: 10.1681/ASN. 
CONCLUSION  
CL-11 plays a pathogenic role in the development of renal tubulointerstitial 
fibrosis in chronic kidney injury. 
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Weiju Wu, Chengfei Liu, Conrad A. Farrar, Liang Ma, Xia Dong, Steven S. 
Sacks, Ke Li, & Wuding Zhou. Collectin-11 is required for the development 
of renal tubulointerstitial fibrosis. J Am Soc Nephrol. Published ahead of 
print July 27, 2017.  dio: 
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Significant statement 
 
Collectin 11 (CL-11) is known to play important roles in embryonic development and host 
defence, as well as acute renal injury. However, the impact of CL-11 on chronic 
inflammation and tissue fibrosis is presently unknown. This manuscript reports a previously 
unknown pathogenic role for CL-11 in the development of tubulointerstitial fibrosis. It also 
defines two novel cellular mechanisms by which CL-11 promotes inflammatory cell migration 
and stimulates renal fibroblast proliferation that contribute to the development of 
tubulointerstitial fibrosis. This study provides new insight into pathogenesis of 
tubulointerstitial fibrosis and opens new avenues for studying the roles of CL-11 in renal 
fibrosis mediated by other causes and tissue fibrosis in other organs. 
 
 
Page 42 of 42
ScholarOne support: 888-503-1050
Journal of the American Society of NEPHROLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
